July 31, 2012
COLORADO SPRINGS, Colo.-- Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges is excited to announce the finalization of a deal with German botanical product company, Dupetit Natural Products, GmbH. Cannabis Science and Dupetit Natural Products have teamed together to develop new products using our combined cannabinoid expertise. The Joint Venture will immediately release the Cannabis Science current product line, Dupetit Natural products, and new Jointly developed product lines in the USA, Europe, and Internationally.
The Joint Venture Agreement signed with Dupetit is designed to release products immediately in the developing European market and the United States thereby expanding our international presence. The deal will bring new products, revenues, and executive management to Cannabis Science’s expanding operations. Dupetit has established itself in the European markets and around the world, while meeting Cannabis Science’s standards to ensure the utmost in quality control and stringent procedures. Cannabis Science has great confidence the new jointly developed products and the current Dupetit product line will be embraced nation wide and internationally.
News 
Market Data 
Discover 
